Imsidolimab, an anti-interleukin-36 receptor monoclonal antibody, for the treatment of generalized pustular psoriasis: results from the phase II GALLOP trial

Richard B. Warren, Jóhann E. Guðjónsson, Andrzej Kaszuba et al.|British Journal of Dermatology|2023

Cited by 57